169 related articles for article (PubMed ID: 11817673)
1. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro.
Shimane T; Asano K; Mizutani T; Suzaki H
In Vivo; 1999; 13(6):503-6. PubMed ID: 10757045
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
[TBL] [Abstract][Full Text] [Related]
4. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.
Suzaki H; Asano K; Ohki S; Kanai K; Mizutani T; Hisamitsu T
Mediators Inflamm; 1999; 8(4-5):199-204. PubMed ID: 10704073
[TBL] [Abstract][Full Text] [Related]
5. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
6. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
7. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture.
Oyama T; Sakuta T; Matsushita K; Maruyama I; Nagaoka S; Torii M
J Periodontol; 2000 Oct; 71(10):1546-53. PubMed ID: 11063386
[TBL] [Abstract][Full Text] [Related]
8. Suppressive activity of a macrolide antibiotic, roxithromycin on co-stimulatory molecule expression on mouse splenocytes in vivo.
Kawazu K; Kurokawa M; Asano K; Mita A; Adachi M
Mediators Inflamm; 2000; 9(1):39-43. PubMed ID: 10877454
[TBL] [Abstract][Full Text] [Related]
9. Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-alpha (TNF-alpha) secretion from cultured mouse mast cells.
Matsuo S; Takayama S
In Vivo; 1998; 12(5):481-4. PubMed ID: 9827354
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.
Bosnar M; Bosnjak B; Cuzic S; Hrvacic B; Marjanovic N; Glojnaric I; Culic O; Parnham MJ; Erakovic Haber V
J Pharmacol Exp Ther; 2009 Oct; 331(1):104-13. PubMed ID: 19633061
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory action of roxithromycin on histamine release and prostaglandin D2 production from beta-defensin 2-stimulated mast cells.
Kase K; Hua J; Yokoi H; Ikeda K; Nagaoka I
Int J Mol Med; 2009 Mar; 23(3):337-40. PubMed ID: 19212651
[TBL] [Abstract][Full Text] [Related]
12. Suppression of co-stimulatory molecule expressions on splenic B lymphocytes by a macrolide antibiotic, roxithromycin in vitro.
Asano K; Suzuki M; Shimane T; Suzaki H
Int Immunopharmacol; 2001 Jul; 1(7):1385-92. PubMed ID: 11460318
[TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A.
Zhu FG; Gomi K; Marshall JS
J Immunol; 1998 Sep; 161(5):2541-51. PubMed ID: 9725254
[TBL] [Abstract][Full Text] [Related]
14. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
Galatowicz G; Ajayi Y; Stern ME; Calder VL
Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
[TBL] [Abstract][Full Text] [Related]
15. Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines.
Yoshimura T; Kurita C; Yamazaki F; Shindo J; Morishima I; Machida K; Sumita T; Horiba M; Nagai H
Biol Pharm Bull; 1995 Jun; 18(6):876-81. PubMed ID: 7550124
[TBL] [Abstract][Full Text] [Related]
16. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M
J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640
[TBL] [Abstract][Full Text] [Related]
17. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
J Dermatol Sci; 2005 Sep; 39(3):175-82. PubMed ID: 16140218
[TBL] [Abstract][Full Text] [Related]
18. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo.
Konno S; Asano K; Kurokawa M; Ikeda K; Okamoto K; Adachi M
Int Arch Allergy Immunol; 1994 Nov; 105(3):308-16. PubMed ID: 7920033
[TBL] [Abstract][Full Text] [Related]
19. [Effects of roxithromycin on proliferation and activation of mast cells].
Shimane T; Asano K; Susaki H
Jpn J Antibiot; 2001 Dec; 54 Suppl C():72-4. PubMed ID: 12575423
[No Abstract] [Full Text] [Related]
20. Acetylsalicylic acid-induced release of HSP70 from mast cells results in cell activation through TLR pathway.
Mortaz E; Redegeld FA; Nijkamp FP; Wong HR; Engels F
Exp Hematol; 2006 Jan; 34(1):8-18. PubMed ID: 16413386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
